The challenges in data integration - heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus.
Clinical trials
Data harmonisation
Data integration
Lupus
Pooled analysis
Journal
BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545
Informations de publication
Date de publication:
24 06 2020
24 06 2020
Historique:
received:
23
09
2019
accepted:
19
06
2020
entrez:
26
6
2020
pubmed:
26
6
2020
medline:
25
6
2021
Statut:
epublish
Résumé
Individual clinical trials and cohort studies are a useful source of data, often under-utilised once a study has ended. Pooling data from multiple sources could increase sample sizes and allow for further investigation of treatment effects; even if the original trial did not meet its primary goals. Through the MASTERPLANS (MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches) national consortium, focused on Systemic Lupus Erythematosus (SLE), we have gained valuable real-world experiences in aligning, harmonising and combining data from multiple studies and trials, specifically where standards for data capture, representation and documentation, were not used or were unavailable. This was not without challenges arising both from the inherent complexity of the disease and from differences in the way data were captured and represented across different studies. Data were, unavoidably, aligned by hand, matching up equivalent or similar patient variables across the different studies. Heterogeneity-related issues were tackled and data were cleaned, organised and combined, resulting in a single large dataset ready for analysis. Overcoming these hurdles, often seen in large-scale data harmonization and integration endeavours of legacy datasets, was made possible within a realistic timescale and limited resource by focusing on specific research questions driven by the aims of MASTERPLANS. Here we describe our experiences tackling the complexities in the integration of large, diverse datasets, and the lessons learned. Harmonising data across studies can be complex, and time and resource consuming. The work carried out here highlights the importance of using standards for data capture, recording, and representation, to facilitate both the integration of large datasets and comparison between studies. Where standards are not implemented at the source harmonisation is still possible by taking a flexible approach, with systematic preparation, and a focus on specific research questions.
Sections du résumé
BACKGROUND
Individual clinical trials and cohort studies are a useful source of data, often under-utilised once a study has ended. Pooling data from multiple sources could increase sample sizes and allow for further investigation of treatment effects; even if the original trial did not meet its primary goals. Through the MASTERPLANS (MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches) national consortium, focused on Systemic Lupus Erythematosus (SLE), we have gained valuable real-world experiences in aligning, harmonising and combining data from multiple studies and trials, specifically where standards for data capture, representation and documentation, were not used or were unavailable. This was not without challenges arising both from the inherent complexity of the disease and from differences in the way data were captured and represented across different studies.
MAIN BODY
Data were, unavoidably, aligned by hand, matching up equivalent or similar patient variables across the different studies. Heterogeneity-related issues were tackled and data were cleaned, organised and combined, resulting in a single large dataset ready for analysis. Overcoming these hurdles, often seen in large-scale data harmonization and integration endeavours of legacy datasets, was made possible within a realistic timescale and limited resource by focusing on specific research questions driven by the aims of MASTERPLANS. Here we describe our experiences tackling the complexities in the integration of large, diverse datasets, and the lessons learned.
CONCLUSIONS
Harmonising data across studies can be complex, and time and resource consuming. The work carried out here highlights the importance of using standards for data capture, recording, and representation, to facilitate both the integration of large datasets and comparison between studies. Where standards are not implemented at the source harmonisation is still possible by taking a flexible approach, with systematic preparation, and a focus on specific research questions.
Identifiants
pubmed: 32580708
doi: 10.1186/s12874-020-01057-0
pii: 10.1186/s12874-020-01057-0
pmc: PMC7313210
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
164Subventions
Organisme : Medical Research Council
ID : MR/M01665X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N00583X/1
Pays : United Kingdom
Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Rheumatology (Oxford). 2018 Mar 1;57(3):470-479
pubmed: 29216396
BMJ Open. 2017 Dec 14;7(12):e018647
pubmed: 29247106
Emerg Themes Epidemiol. 2013 Nov 21;10(1):12
pubmed: 24257327
N Engl J Med. 2011 Nov 17;365(20):1886-95
pubmed: 22087680
Arthritis Rheum. 2012 Apr;64(4):1215-26
pubmed: 22231479
Int J Epidemiol. 2010 Oct;39(5):1383-93
pubmed: 20813861
Stud Health Technol Inform. 2011;169:185-9
pubmed: 21893739
Am J Kidney Dis. 2015 Oct;66(4):583-90
pubmed: 26088508
Arthritis Rheum. 2010 Jan;62(1):222-33
pubmed: 20039413